文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

利用肠道仿生技术揭示多菌株化合物的益处及其健康影响机制。

Disclosing the benefits of multi-strain compounds and their health impact mechanisms utilizing intestinal biomimetic technology.

作者信息

Liao Jiahao, Huang Jianyu, Li Xiaoqiong, Kuang Jian, Li Jianqiang, Wang Weiwei, Li Jinjun

机构信息

College of Animal Science, Shanxi Agricultural University, Taigu, China.

State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-Products, Institute of Food Science, Zhejiang Academy of Agricultural Sciences, Hangzhou, China.

出版信息

Front Microbiol. 2025 May 15;16:1550913. doi: 10.3389/fmicb.2025.1550913. eCollection 2025.


DOI:10.3389/fmicb.2025.1550913
PMID:40444007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12119514/
Abstract

The gut microbiota plays a vital function in preserving intestinal homeostasis and general health. This study examined the impacts of a composite probiotic based on an fermentation system and an organoid interaction research platform to investigate the effects of composite probiotics. 4P, investigating the impact of gut barrier function through the utilization of and organoid models. Our findings revealed that 4P demonstrated excellent capabilities for producing short-chain fatty acids, modulating intestinal gas metabolism, and regulating oxidative-reduction potential. Furthermore, the individual strains that comprise 4P were selected for subsequent organoid studies based on previous strain culture experiments. Our results suggest that 4P and its individual strains hold promise for preserving the gut barrier integrity and function, thereby potentially offering therapeutic benefits in the context of intestinal disorders. These findings underscore the importance of exploring the mechanistic actions of composite probiotics in maintaining gut health and preventing diseases.

摘要

肠道微生物群在维持肠道稳态和整体健康方面发挥着至关重要的作用。本研究基于发酵系统和类器官相互作用研究平台,检测了复合益生菌的影响,以探究复合益生菌的作用效果。通过利用4P并借助类器官模型研究肠道屏障功能的影响。我们的研究结果表明,4P在产生短链脂肪酸、调节肠道气体代谢以及调节氧化还原电位方面表现出卓越的能力。此外,根据之前的菌株培养实验,挑选出构成4P的各个菌株用于后续的类器官研究。我们的结果表明,4P及其各个菌株有望维持肠道屏障的完整性和功能,从而可能在肠道疾病方面提供治疗益处。这些发现强调了探索复合益生菌在维持肠道健康和预防疾病方面的作用机制的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ab/12119514/579efe341c56/fmicb-16-1550913-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ab/12119514/6a0cc182b39d/fmicb-16-1550913-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ab/12119514/df291c608ffb/fmicb-16-1550913-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ab/12119514/f2247ebf5114/fmicb-16-1550913-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ab/12119514/9ab8db6cc8cd/fmicb-16-1550913-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ab/12119514/672fd80bc817/fmicb-16-1550913-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ab/12119514/c63b403c0487/fmicb-16-1550913-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ab/12119514/d6d360dde5a4/fmicb-16-1550913-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ab/12119514/579efe341c56/fmicb-16-1550913-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ab/12119514/6a0cc182b39d/fmicb-16-1550913-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ab/12119514/df291c608ffb/fmicb-16-1550913-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ab/12119514/f2247ebf5114/fmicb-16-1550913-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ab/12119514/9ab8db6cc8cd/fmicb-16-1550913-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ab/12119514/672fd80bc817/fmicb-16-1550913-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ab/12119514/c63b403c0487/fmicb-16-1550913-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ab/12119514/d6d360dde5a4/fmicb-16-1550913-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ab/12119514/579efe341c56/fmicb-16-1550913-g008.jpg

相似文献

[1]
Disclosing the benefits of multi-strain compounds and their health impact mechanisms utilizing intestinal biomimetic technology.

Front Microbiol. 2025-5-15

[2]
Intestinal organoid technology and applications in probiotics.

Crit Rev Food Sci Nutr. 2025

[3]
Multi-Species Probiotic Strain Mixture Enhances Intestinal Barrier Function by Regulating Inflammation and Tight Junctions in Lipopolysaccharides Stimulated Caco-2 Cells.

Microorganisms. 2023-3-3

[4]
Probiotics and gut microbiota: mechanistic insights into gut immune homeostasis through TLR pathway regulation.

Food Funct. 2022-7-18

[5]
Probiotic Consortia Protect the Intestine Against Radiation Injury by Improving Intestinal Epithelial Homeostasis.

Int J Radiat Oncol Biol Phys. 2024-9-1

[6]
Cellulolytic produces a variety of short-chain fatty acids and has potential as a probiotic.

Microbiol Spectr. 2024-4-2

[7]
Probiotic-fermented traditional Chinese herbal medicine, a promising approach to maintaining the intestinal microecology.

J Ethnopharmacol. 2025-1-30

[8]
Comprehensive probiogenomics analysis of the commensal Escherichia coli CEC15 as a potential probiotic strain.

BMC Microbiol. 2023-11-27

[9]
The antioxidant strain AS21 and ameliorate DSS-induced colitis in mice by remodeling the assembly of intestinal microbiota and improving gut functions.

Food Funct. 2024-2-19

[10]
Prophylactic use of probiotics as an adjunctive treatment for ischemic stroke via the gut-spleen-brain axis.

Brain Behav Immun. 2025-1

本文引用的文献

[1]
Inhibitory Effect of and on Citrobacter Colitis in Mice.

Microorganisms. 2024-4-3

[2]
Antiaging Effects of Human Fecal Transplants with Different Combinations of LTBB21J1 and LTL1361 in d-Galactose-Induced Mice.

J Agric Food Chem. 2024-5-1

[3]
Immunoregulatory role of the gut microbiota in inflammatory depression.

Nat Commun. 2024-4-8

[4]
Epithelial-immune cell crosstalk for intestinal barrier homeostasis.

Eur J Immunol. 2024-6

[5]
SC06 Relieving Intestinal Inflammation by Modulating Intestinal Stem Cells Proliferation and Differentiation via AhR/STAT3 Pathway in LPS-Challenged Piglets.

J Agric Food Chem. 2024-3-27

[6]
Crohn's disease.

Lancet. 2024-3-23

[7]
Next generation probiotics: Engineering live biotherapeutics.

Biotechnol Adv. 2024

[8]
safety and functional characterization of the novel strain CGI314.

Front Microbiol. 2024-1-10

[9]
Short chain fatty acids inhibit corneal inflammatory responses to TLR ligands via the ocular G-protein coupled receptor 43.

Ocul Surf. 2024-4

[10]
The NF-κB signaling system in the immunopathogenesis of inflammatory bowel disease.

Sci Signal. 2024-1-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索